指南与共识类风湿关节炎

2023年美国风湿病学会与美国髋膝关节外科医师协会临床实践指南:对有症状的中重度骨关节炎或晚期有症状的骨坏死继发关节炎且非手术治疗无效的患者,择期髋或膝关节置换术最佳时机的选择

2023 American College of Rheumatology and American Association of Hip and Knee Surgeons Clinical Practice Guideline for the Optimal Timing of Elective Hip or Knee Arthroplasty for Patients With Symptomatic Moderate-to-Severe Osteoarthritis or Advanced Symptomatic Osteonecrosis With Secondary Arthritis for Whom Nonoperative Therapy Is Ineffective.
指南 / 共识 · Arthritis Care Res (Hoboken) · 2023-09-25

该指南针对有症状且影像学表现为中重度骨关节炎或晚期有症状的骨坏死继发关节炎、非手术治疗无效并选择行择期全髋或全膝关节置换术(TJA)的患者,就TJA的最佳时机提出推荐。工作组提出13个PICO问题,经系统文献综述后用GRADE方法评级,由包括13名医师和患者在内的投票专家组达成共识:有条件推荐不要为继续非手术治疗而推迟TJA,有条件推荐为减少或戒除尼古丁而推迟TJA,有条件推荐糖尿病患者为改善血糖控制而推迟TJA(但未确定具体指标或水平),并认为肥胖本身不是推迟理由但应强烈鼓励减重。所有推荐证据质量均为低或极低。

要点

  • 有条件推荐不要为继续物理治疗、非甾体抗炎药、助行器具或关节腔内注射等非手术治疗而推迟TJA。
  • 有条件推荐为减少或戒除尼古丁而推迟TJA;有条件推荐糖尿病患者为改善血糖控制而推迟TJA,但未确定具体指标或水平。
  • 肥胖本身不是推迟理由,但应强烈鼓励减重并讨论手术风险增加;严重畸形、骨丢失或神经性关节患者有条件推荐不推迟。

核心结论

  • 该指南就非手术治疗无效、已选择择期TJA的有症状影像学中重度骨关节炎或晚期有症状骨坏死继发关节炎患者,给出关于TJA最佳时机的循证推荐,以改善疼痛、功能、感染、住院和1年死亡等患者重要结局。
  • 作者承认证据质量低,主要由于间接性,并希望未来研究能进一步完善推荐。

研究设计与样本

  • 由美国风湿病学会与美国髋膝关节外科医师协会制定,提出13个临床相关的PICO问题,经系统文献综述后用GRADE方法对证据质量评级(高、中、低或极低)并制作证据表,由包括13名医师和患者在内的投票专家组讨论至就推荐方向和强度达成共识。

主要发现

  • 专家组有条件推荐不要为继续非手术治疗(包括物理治疗、非甾体抗炎药、助行器具和关节腔内注射)而推迟TJA。
  • 专家组有条件推荐为减少或戒除尼古丁而推迟TJA。
  • 专家组有条件推荐糖尿病患者为更好的血糖控制而推迟TJA,但未确定具体指标或水平。
  • 专家组共识认为肥胖本身不是推迟的理由,但应强烈鼓励减重,并应讨论手术风险增加。
  • 专家组有条件推荐对严重畸形或骨丢失患者、神经性关节患者不推迟TJA;所有推荐证据质量均评为低或极低。

关键数值与推荐

  • 有条件推荐不要为继续非手术治疗(物理治疗、非甾体抗炎药、助行器具、关节腔内注射)而推迟TJA。
  • 有条件推荐为减少或戒除尼古丁而推迟TJA。
  • 有条件推荐糖尿病患者为更好的血糖控制而推迟TJA,但未确定具体指标或水平。
  • 肥胖本身不是推迟理由(专家组共识),但应强烈鼓励减重并讨论手术风险增加。
  • 有条件推荐对严重畸形或骨丢失患者、神经性关节患者不推迟TJA;所有推荐证据质量均评为低或极低。

临床怎么用

  • 对非手术治疗无效、已选择择期TJA的中重度骨关节炎或晚期有症状骨坏死继发关节炎患者,按本指南有条件推荐不因继续非手术治疗而推迟手术。
  • 按本指南有条件推荐,可为减少或戒除尼古丁而推迟TJA,糖尿病患者可为更好的血糖控制而推迟TJA(未确定具体指标或水平)。
  • 按本指南,肥胖本身不是推迟TJA的理由,但应强烈鼓励减重并讨论手术风险增加;严重畸形、骨丢失或神经性关节患者有条件推荐不推迟。
  • 本指南全部推荐的证据质量均为低或极低。

局限性

  • 所有推荐的证据质量均评为低或极低。
  • 作者承认证据质量低主要由于间接性,并希望未来研究能进一步完善推荐。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To develop evidence-based consensus recommendations for the optimal timing of hip and knee arthroplasty to improve patient-important outcomes including, but not limited to, pain, function, infection, hospitalization, and death at 1 year for patients with symptomatic and radiographic moderate-to-severe osteoarthritis or advanced symptomatic osteonecrosis with secondary arthritis of the hip or knee who have previously attempted nonoperative therapy, and for whom nonoperative therapy was ineffective, and who have chosen to undergo elective hip or knee arthroplasty (collectively referred to as TJA). METHODS: We developed 13 clinically relevant population, intervention, comparator, outcomes (PICO) questions. After a systematic literature review, the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach was used to rate the quality of evidence (high, moderate, low, or very low), and evidence tables were created. A Voting Panel, including 13 physicians and patients, discussed the PICO questions until consensus was achieved on the direction (for/against) and strength (strong/conditional) of the recommendations. RESULTS: The panel conditionally recommended against delaying TJA to pursue additional nonoperative treatment including physical therapy, nonsteroidal antiinflammatory drugs, ambulatory aids, and intraarticular injections. It conditionally recommended delaying TJA for nicotine reduction or cessation. The panel conditionally recommended delay for better glycemic control for patients who have diabetes mellitus, although no specific measure or level was identified. There was consensus that obesity by itself was not a reason for delay, but that weight loss should be strongly encouraged, and the increase in operative risk should be discussed. The panel conditionally recommended against delay in patients who have severe deformity or bone loss, or in patients who have a neuropathic joint. Evidence for all recommendations was graded as low or very low quality. CONCLUSION: This guideline provides evidence-based recommendations regarding the optimal timing of TJA in patients who have symptomatic and radiographic moderate-to-severe osteoarthritis or advanced symptomatic osteonecrosis with secondary arthritis for whom nonoperative therapy was ineffective to improve patient-important outcomes, including pain, function, infection, hospitalization, and death at 1 year. We acknowledge that the evidence is of low quality primarily due to indirectness and hope future research will allow for further refinement of the recommendations.

来源:Arthritis Care Res (Hoboken),查看原文。版权归原作者所有。

引用

  1. Hannon CP, Goodman SM, Austin MS, et al. 2023 American College of Rheumatology and American Association of Hip and Knee Surgeons Clinical Practice Guideline for the Optimal Timing of Elective Hip or Knee Arthroplasty for Patients With Symptomatic Moderate-to-Severe Osteoarthritis or Advanced Symptomatic Osteonecrosis With Secondary Arthritis for Whom Nonoperative Therapy Is Ineffective. Arthritis Care Res (Hoboken). 2023. PMID: 37743767. doi:10.1002/acr.25175

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。